Filing Details

Accession Number:
0001209191-16-124062
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-27 16:38:06
Reporting Period:
2016-05-25
Filing Date:
2016-05-27
Accepted Time:
2016-05-27 16:38:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1518733 M Douglas Oort Van 12701 Commonwealth Drive Suite 9
Fort Myers FL 33913
Chairman And Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-25 600,000 $1.71 2,275,000 No 4 M Direct
Common Stock Disposition 2016-05-25 118,613 $8.65 2,156,387 No 4 F Direct
Common Stock Disposition 2016-05-26 98,387 $8.69 2,058,000 No 4 S Direct
Common Stock Disposition 2016-05-27 383,000 $8.74 1,675,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-05-25 600,000 $1.71 600,000 $1.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
200,000 2013-02-14 2017-02-14 No 4 X Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 187,500 Indirect Conundrum Capital Partners
Common Stock 1,675,000 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy $7.15 2017-04-20 2021-04-20 472,527 472,527 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-20 472,527 472,527 Direct
Footnotes
  1. Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr. VanOort is a managing partner of ConundrumCapital Partners, LLC.
  2. Shares withheld by NeoGenomics Inc. to satisfy the cost of the shares in connection with the May 25, 2016 stock option exercise.
  3. Closing stock price on date of exercise, May 25, 2016.
  4. Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. VanOort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014.
  5. On April 20, 2016, Mr. VanOort was granted 472,527 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  6. On February 14, 2012, Mr. VanOort was granted options to purchase 800,000 shares. These shares vest equally over each of the first four anniversaries of the grant date. On May 25, 2016. Mr. VanOort exercised 600,000 of these options leaving a balance of 200,000 options.